Next Article in Journal
New Promising Targets for Synthetic Omptin-Based Peptide Vaccine against Gram-Negative Pathogens
Previous Article in Journal
In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice
Article Menu

Article Versions

Export Article

Open AccessMeeting Report
Vaccines 2019, 7(2), 35; https://doi.org/10.3390/vaccines7020035

20th International Conference on Emerging Infectious Diseases in the Pacific Rim Organized by the United States-Japan Cooperative Medical Sciences Program (USJCMSP)

1
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
2
Office of Global Research, NIAID, NIH, Bethesda, MD 20892, USA
3
Division of Microbiology and Infectious Diseases, NIAID, NIH, Bethesda, MD 20892, USA
4
Office of the Director, NIAID, NIH, Bethesda, MD 20892, USA
5
Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
6
National Institute of Infectious Diseases, Shinjuku-ku, Tokyo 162-8640, Japan
7
Department of Research Promotion, Japan Agency for Medical Research and Development, Chiyoda-ku, Tokyo 100-0004, Japan
8
CAS Key Laboratory of Pathogenic Microbiology and Immunology, Chinese Academy of Sciences Institute of Microbiology, Beijing 100101, China
*
Authors to whom correspondence should be addressed.
Received: 1 February 2019 / Revised: 22 March 2019 / Accepted: 27 March 2019 / Published: 2 April 2019
PDF [776 KB, uploaded 2 April 2019]

Abstract

The 20th International Conference on Emerging Infectious Diseases in the Pacific Rim to3ok place in Shenzhen, China on January 8–9, 2018 followed by meetings of the acquired immunodeficiency syndrome (AIDS)/immunology, acute respiratory infections, cancer, hepatitis, and viral diseases panels on January 10–11. The conference was organized as part of the United States-Japan Cooperative Medical Sciences Program (USJCMSP) by the Japan Agency for Medical Research and Development (AMED) and the U.S. National Institutes of Health (NIH) and was locally hosted by the Shenzhen Third People’s Hospital and the Chinese Academy of Sciences (CAS) Institute of Microbiology. The conference provides the basis for networking and fostering of collaboration opportunities between researchers in Southeast Asia and the United States based on the scientific and interactive platform of the USJCMSP and takes place in the region on an annual basis. This report summarizes the discussions and conclusions from the conference.
Keywords: emerging infectious diseases; pacific rim emerging infectious diseases; pacific rim
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

USJCMSP AIDS, ARI, Cancer, Hepatitis, Immunology and Viral Diseases Panels; Bernabe, K.G.; Lu, K.T.; Handley, F.G.; Griffin, D.E.; Kurane, I.; Iwamoto, A.; Gao, G.F.; Krammer, F. 20th International Conference on Emerging Infectious Diseases in the Pacific Rim Organized by the United States-Japan Cooperative Medical Sciences Program (USJCMSP). Vaccines 2019, 7, 35.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top